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Abstract: The United Kingdom National Health Service (NHS) is about to commence upon major 
computerisation of its processes as part of a government plan of modernisation. One of these is the 
Electronic Transmission of Prescription (ETP). To achieve success it is important to know what 
benefits are expected from the new system and what barriers to adoption the systems will face.  This 
paper reviews substantial ETP published material, and identifies seventeen issues that need to be 
addressed. These issues are categorised under 4 major headings of stakeholders, cost, technology, and 
current process and practice, and are then further classified as positive or negative influences on the 
project’s success.  Many of these influences will be common to most of the computerisation projects to 
be undertaken by the NHS, and therefore this paper has wider applicability than ETP.  
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1. Introduction 
The United Kingdom (UK) government is supporting multiple technological 
modernisation projects within the UK National Health Service.  Projects aimed at the 
introduction of electronic systems for appointment booking, transmission of 
laboratory results, patient records (EPR) and the transfer of prescriptions (ETP) have 
been established.  The government’s aim is to modernise healthcare through re-
building “the NHS for the 21st Century, true to its priorities but radically reformed in 
their implementation” [1].  In this paper we focus on the issues surrounding the 
reform of one of these health care processes – the prescription processing system.      
 
The UK NHS came into being in 1948 and since then has provided fixed or zero cost 
medical services to all UK citizens.  One of the fixed cost medical services is the UK 
drug prescription system controlled by a government organisation called the 
Prescription Pricing Authority (PPA).  The NHS also provides free prescriptions to a 
large proportion of the population through exemptions for reasons such as age or 
severe illness.  With the recent introduction of a National Plan of Reform for the NHS 
[1] came a goal to adopt a system for ETP by 2004 to replace the current paper based 
system which was introduced in 1948. 
 
However, the fervour for ETP is not new.  Over the past decade multiple academic 
and other publications [2-7, 9, 11-18, 20-30, 34] have been produced aimed at 
realising the dream of ETP integration into the health care system.  In this paper we 
provide an analysis of the benefits and barriers towards the realisation of ETP 
integration into the UK NHS.  We provide this analysis through research work we 
carried out into the UK prescription system and a critical appraisal of prior literature 
in the field.   We have categorised our findings under four major influencing factors, 
namely: the influence of stakeholders, the influence of technology, the influence of 
cost and the influence of current process and practice. 
2. The Influence of Stakeholders 
It is well recognised that organisational change is often resisted and stakeholder 
resistance to change is frequently stated as one of the major reasons for project 
failure. Furthermore, governments are not always the best organisations to manage 
large IT projects. We have found that stakeholders can influence the implementation 
of ETP in three areas described below: 
 
?? Government Led 
 
“Large (UK) government IT projects seem to have a habit of going wrong.  They are 
often late, over budget or both” [2].  The UK government must ensure that ETP and 
other IT reform projects within the NHS do not follow this organisational trait of 
failure.  However, the prescription process with all its foibles is thought to be an 
extremely large and complex IT project, providing difficulties for any ETP system 
developer [3][4].  We believe that because the NHS is both national and government 
run, that these factors in themselves may be significant impediments to the successful 
implementation of ETP. Furthermore, the authors believe the prescription processing 
system falls into the bracket of an ‘irreversible’ system as defined by O. Hanseth and 
E. Monteiro [8].  This is a system that consists of “large, complex and highly 
entrenched actor-networks” [8].  Hanseth and Monteiro believe that “due to the 
interdependencies of the elements such networks are difficult to change” [8].  Thus 
the omens for the introduction of ETP are not good. 
 
?? Senior Management and Clinician Resistance to Change 
 
Stakeholder levels of commitment to the adoption of ETP are highlighted as a major 
potential barrier by many researchers [3][9][6].  We have also found this in previous 
research projects [10].  It is often easier for stakeholders to carry on working with 
systems and procedures which they have used all of their professional lives rather 
than undertake the task of adopting new ones. In a study carried out in public health 
care organisations in Hong Kong, investigating the factors affecting the adoption of 
telemedicine technology, it was found that the “collective attitude of medical staff 
towards telemedicine and its enabled services was the most significant factor” [9] in 
deciding whether to implement telemedicine applications or not. In research carried 
out be Kember Associates on behalf of Pharmed, physicians “were ambivalent 
towards computer technology, saying that it was of limited importance in their work, 
preferring paper records” [11].  This problem was also indicated as a key barrier to 
be overcome by a research team at Huddersfield University [12]. Whalley and Davies, 
in their study about implementing IT in NHS hospitals [13] noted “Doctors used their 
power to limit the level of organisational changes that were being introduced in 
tandem with the technical developments [of a Patient Management System]” Thus 
winning the hearts and minds of senior professionals in the NHS will be a critical 
successful factor in the UK Government’s proposed roll out of ETP. 
 
?? GPs and Pharmacists Concerns about its effect on Practice and Patient Care 
 
There is concern amongst stakeholders about the effect ETP will have on operational 
practices and patient service (see later). GP’s are worried that improvements made to 
the repeat prescription process may lead to loss of contact with patients [11].  
Pharmacists are worried about directed prescriptions used within a number of the ETP 
pilot system designs and feel that this could increase competition between pharmacies 
[11].  In the socio-technical study carried out by Huddersfield University [12] it was 
found that clinicians and pharmacists are most concerned about the restrictions that 
may be placed on their present operations with the introduction of ETP into their 
practices, for example, the ‘loaning’ of patient medication and procedures for 
prescription modification. 
 
Clearly the many concerns and fears that the professionals have will need to be 
allayed, and this should all be part of the change management process.  There may 
also be patient issues with the new system that the professionals will need to deal with 
on a daily basis.  In the results of previous research carried out by Kember Associates 
[48] only a minority of patients did not like the idea of electronic prescribing.  
However, these views were based on the understanding that the introduction of 
electronic prescriptions would lead to time and cost savings.  Clearly if in reality the 
patients receive no benefits from the introduction of such a system then their views 
may change and their opposition to the system may grow. 
3. The Influence of Technology 
Technological availability is one of the major forces behind the government’s radical 
reforms of the NHS.  The introduction of ETP is not just a technical project as is 
shown above, although technology will have an influence on its successful integration 
into the health service.  In this section we detail three technological factors that are 
significant in the introduction of ETP. 
 
?? Better Communication Channels 
 
ETP will require the installation of a resilient high bandwidth communications 
infrastructure to support the high demands of the prescription processing system.  
This infrastructure, when in place, should enable better communications between 
stakeholders [14][12][4]. H.Middleton [5] believes that “the goal of seamless care 
between hospitals, GPs and community care would be a step nearer, if not a reality, 
with the electronic transmission of information”.  Stronger communication channels 
will not only support ETP but many of the reformed NHS services. This should be an 
enabling influence.  However, it is not the availability of the technology that results in 
better communication channels.  It is the stakeholders’ acceptance and use of the 
technology that will result in benefits, for example, the transmission of over the 
counter (OTC) medication purchase information between pharmacy and GP.  
 
?? Privacy and Security 
 
There can be no doubt that ensuring the privacy and security of patient identifiable 
data within an ETP system is extremely important [7][15][16]. Research carried out 
with GP’s [17], pharmacists [18] and patients [48] reveals that all user groups are 
worried about the potential threat of hackers and insecure ETP systems leaking 
personal medical information.  There is not only the threat of patient privacy but also 
that of system abuse.  In one of the previous implementations of ETP in the Wirral 
Hospital NHS Trust a serious security problem arose, that of “a nurse using a doctors 
password to prescribe illegally” [5].  The availability of high risk electronic services 
such as banking over the Internet, shows that privacy and security in an ETP system 
can be achieved.  In our previous research we have shown that medical information 
can be made available across a public network without public disclosure of the 
transmitted information [10].  Never the less, “the risks perceived or otherwise, of lax 
security may be a factor in discouraging trusts from actively driving forward the 
implementation of EPMA  (Electronic prescribing and medicines administration)” [3].  
In [12] all users thought that system security and the potential for system abuse were 
relatively significant barriers to the success of an ETP system. Consequently, we 
believe the major issue may not be in implementing the actual technological security 
capability, but rather in convincing the stakeholders of the safety of an electronically 
secured ETP system. 
 
?? Technical Problems and Development Process Complexity 
 
As stated earlier, ETP is a large and complex IT project. It has many foibles and 
complex issues such as: the treatment of locums within the NHS who often work for 
many different practices [5], catering for GP mobility such as during home visits, the 
use of many different application systems in the NHS [6], and the varying state of 
organisational computerisation [7].  All this leads to complexity in both technical 
design and implementation. Technical problems have also been identified as potential 
issues to be overcome in the adoption of ETP in the NHS.  Identified problems 
include: potential downtime [19], transmission reliability [7], extent of practice 
computerisation [12], maintenance of systems [5], message integrity [12] and legacy 
system integration.   
 
It is believed the software development process is fraught with problems including 
local customisation, user friendliness, system changeover and clinical decision 
support integration issues [3]. In our field work, we noticed the use of many different 
prescribing and dispensing systems in the sites we visited.  Some of these were old 
MS-DOS based systems, others were newer Windows based systems.  The dispensing 
performance at the pharmacies differed depending upon the dispensing application 
being used, suggesting some applications are quicker and easier to use than others.  
Clearly a large amount of work will be required in optimising the electronic systems 
when ETP is introduced, as the older MS-DOS based systems, which ironically 
seemed to be the most efficient, will be lost. Ultimately we believe that the technical 
issues in ETP system provision are solvable through good system design and 
implementation, but if a poorly designed system is first introduced to users, this can 
have a major negative influence.   
4. The Influence of Cost 
Cost is a major issue in the UK NHS.  The NHS is publicly funded so is accountable 
to the citizens of the UK.  It is often extremely difficult to define the Return on 
Investment (ROI) for technological implementations.  The introduction of ETP is no 
different from a cost perspective. It has to be shown that the implementation of ETP 
can pay for itself without continually draining the NHS of funds.  In this area we 
describe three factors that reflect the influence of cost. 
 
?? Increased Efficiency and Decreased Costs 
 
Multiple researchers expect all stakeholders to benefit from a reduction in the expense 
of the paper prescribing system [29][21][25][49].  In the Huddersfield University 
socio-technical study [12] stakeholders identified resource savings as one of the major 
benefits to be gained from an ETP system. An ETP system should also result in 
efficiency savings [4][20][21].  GP surgeries should benefit from improvements made 
to repeat prescribing (discussed separately) [22] and a reduction in telephone 
prescription queries from pharmacies [7].  Pharmacies should benefit from improved 
efficiency through the reduction in the number of drug queries with GP’s, no 
transcription requirements [23] and savings in prescription collection services [24].  
Pharmacists should also benefit from the overall increased efficiency of the system 
through faster payment cycles [22].  Savings made at pharmacies should hopefully 
translate into “more time available to spend on patient management” [22] and 
“liberate pharmacy time for clinical duties”[25].  Efficiency savings at the PPA 
should be the greatest, with the removal of the transcription of prescriptions and the 
provision of real time access to current prescribing trends. Looking at things from a 
patient’s perspective they “believe the new system will be more convenient for them, 
save them time travelling to a GP surgery and possibly having to travel then to a 
pharmacy to collect their drugs”  [12]. 
 
However, we believe that improvements in efficiency will be extremely difficult to 
achieve especially in the short term. Prescribing GP’s, especially those who are 
already using electronic prescribing software, will notice no efficiency savings in 
ETP. Indeed it may take longer for them to input a password or PIN, for the digital 
signature to be created and the electronic prescription to be transferred, than it does 
today to currently handwrite their signature and give the prescription to the patient. 
(The GP’s should gain efficiency benefits with repeat prescriptions, but this is 
addressed later.)  Pharmaceutical operations at present are heavily time optimised.  
Time savings may only be measured in seconds through the removal of the 
requirement for transcription within ETP.  Technological system requirements may 
even increase the time taken, for example, the introduction of a bar coded prescription 
form may result in time increases because of bar code reading failure rates [26].  The 
only place where efficiency benefits should be realised quickly and definitely is at the 
PPA.  However, during system rollout it is likely that the PPA will be required to run 
parallel systems.  This requirement will, at least in the short term, have an affect on 
the efficiency savings that can be made by it. 
 
?? Fraud Reduction 
 
Fraud within the NHS prescription system has been targeted over the last five years 
and reduced significantly.  Nevertheless, there is still a high level of fraudulent 
activity within the system and many researchers believe that an ETP system can help 
to further reduce this [12][19][27][14].  One of the ways that the PPA may do this is 
by reallocating the resources used in prescription transcribing to fraud reduction.  
However, we believe the best way to reduce fraud would be to introduce an electronic 
authorisation and exemption system such as our own [28].  This would help to focus 
fraud investigations onto a smaller subset of prescriptions. 
 
?? Cost of Transformation 
 
Transforming the legacy paper processing system to an ETP system will not be an 
inexpensive process [30][19][18].  Transformation costs identified include: the 
software development [3], hardware and infrastructure purchases, and the initial 
decreases in productivity as clinicians get used to using ETP instead of paper [19].  
Frank Quinlan, National Co-ordinator of the General Practice Group in Canberra, 
Australia in a 2000 paper on the integration of electronic prescribing into general 
practice in Australia noted that “Computerisation is generally costly, whether 
measured in terms of capital outlay, training, maintenance, length of consultation or 
organisational change” [30].  However, the UK government realises the vast costs of 
informational reform and has a significant budget available, which is far in advance of 
previous NHS IT expenditure levels [31].  
5. The Influence of Current Process and Practice 
Prior to the integration of ETP it is useful to gain an appreciation of what revised 
practices ETP may lead to and what new support processes need to be in place to help 
the integration process.  Overall the changes made to process and practice will have a 
major influence on system acceptance and ultimately on project success.  We have 
identified eight factors of influence within this section. 
 
?? Medication and Transcription Errors 
 
One of the major benefits in the introduction of ETP will come in the form of a 
reduction in medication errors [32][19] and transcription errors [23][18]. Medication 
errors in the present system “often occur because of illegible handwriting, confusing 
drug names and dosage mistakes” [7].  Transcription errors can occur at the PPA and 
pharmacy when the paper prescription is input into the computer system.  It is 
believed that “receiving prescriptions direct will reduce transcription errors” [14].  
At present these problems can result in incorrect dispensation, litigation when 
medication error may result in patient complications [5], administrative errors, 
payment errors and inaccurate prescribing statistical information. From previous 
research [10] the authors have seen that the transcription processes can lead to poor 
data integrity within a system therefore affecting stakeholders’ attitudes.   
 
?? Repeat Prescribing Benefits 
 
One of the main areas where ETP is expected to benefit GPs and pharmacies directly 
is in the transformation of repeat prescribing [22][11]. Repeat prescriptions count for 
an estimated 70% of prescriptions issued in the UK [33], so any gain here will have a 
significant impact.  ETP should “eliminate the need to collect scripts from 
surgery”[14].  Indeed it is estimated that “electronic transmission of prescriptions 
could save pharmacists up to 51.8 working days per year with reference to script 
collection service” [17].  The patient should also benefit from not having to make 
multiple trips to their GP to order to collect repeat prescriptions.  GP’s may also 
benefit through reduced administration time requirements.  However, care must be 
taken to ensure that patients are getting the treatment they require and that ETP does 
not increase the error potential in repeat administration.  For example, some patients 
in receipt of repeat prescriptions, especially the lone or elderly, actually want to visit 
their GP regularly, for the social contact that it affords them.  The potential for errors 
in repeat administration may increase with ETP because of poorly designed systems 
that remove the GP’s opportunity to reflect upon or recall erroneous prescriptions 
before they are dispensed (e.g. the prescription could be transferred immediately to 
the pharmacy after electronic signature). 
 
?? Improved Quality 
 
Prescription quality is an issue in the present paper prescribing system [34][20].  In 
this context, quality refers to conformance to prescription standards, with regards to 
both the drugs that are prescribed and the other data that is included on the 
prescription form, for example, signatures, drug quantities and drug guidance 
information. Drug unavailability, missing signatures, ambiguous drug quantities and 
wrong/ambiguous instructions for drugs are all identified as the most significantly 
occurring prescription errors [12].  Poor quality prescriptions may lead to delays [4], 
illegalities [5] and errors in the dispensation process [35].  ETP has the potential to 
ensure that transmitted prescriptions conform to prescription standards.  For example, 
on an electronic prescription there will always be an electronic signature, or the ETP 
system should refuse to accept it. 
 
The potential for improved prescription quality is highlighted in the results of two 
prior research projects.  Research undertaken in the Derbyshire Royal Infirmary (a 
UK NHS hospital) between 1998-9, found that the quality of prescriptions constructed 
electronically was far superior to that of present paper based prescriptions [34].  A 
study has also been carried out into whether computerised prescribing improves the 
accuracy of drug administration [35].  In the study it was found that computer based 
prescribing produced a lower error rate (5.5%) than manual prescribing (5.7%) even 
after excluding mistimed administration.  Far fewer instances of timing errors (wrong 
timing of drug administration) occurred with computerised prescribing. 
 
?? Improved Practice 
 
The introduction of an ETP system should result in improvements in practice at the 
GP surgery, the pharmacy and the PPA [30][21].  For the GP multiple improvements 
are envisaged from the introduction of ETP with researchers stating “greater 
evaluation and assessment of the practice” [30], “reduced litigation” [5] and 
improved practice through “greater implementation of evidence based treatments and 
guidelines” [30].  At the pharmacy ETP could lead to administrative improvements, 
greater use of automation (e.g. automatic label printing on receipt of an electronic 
prescription and/or automated dispensation). At the PPA real time access to 
prescribing and dispensing patterns can help target health resources and provide an 
early warning system for the community [30].  Real time prescribing statistics could 
also lead to improved public health planning at a governmental level [30].  Note 
however that stakeholders will need to have the time, resources and will to implement 




In prior research this has been identified as a barrier to the successful adoption of ETP 
[23][5].  Recent legislation [36][37][38][39] has been adopted allowing electronic 
signatures on prescriptions within the three UK ETP pilot studies [40][41][42].  
However, there may still be a problem with the legislation in future, for instance in 
the areas of control drugs and repeat prescriptions where ETP could require 
significant changes to legal practice. Thus there is still the potential for 
“inappropriately worded legislation and official guidance” [3].  For example, the 
present legislation does not seem to take account of new practices that only become 
possible once an electronic system is established, such as attaching digital signatures 
to multiple prescriptions in a bulk authorisation mode by simply entering a password 
once.  Whether this should be allowed legally or ethically requires careful 
consideration, research and legislation. 
 
?? Multiple Drug Codes 
 
In May 2000, Dr Michael Daly, Chief Pharmacist with the Royal Wolverhampton 
Hospitals NHS Trust stated that “A fundamental difficulty is the problem of multiple 
drug codes used by individual trusts, hardware vendors and software developers.”  
Dr Daly went on to say “Any single therapeutic entity should have a unique 
identifying drug code, and the development of this unified drug code is an essential 
prerequisite for the rapid and safe development of integrated prescribing 
systems.”[6].  After this, the NHS set up a project to develop a single code for each 
drug, called the NHS Primary Care Drug Dictionary [43].  In December 2002 the 
outcome of this project was presented to the primary care community and now 
practices are beginning to adopt this standard set of drug codes. Migration to this 
standard set should remove this barrier to ETP. But we don’t know how long it will 
take. 
 
?? Education and Implementation 
 
The education and implementation process may also prove a barrier to the successful 
implementation of any ETP system [5][6][29].  “The time and effort needed to change 
from a paper based system – to an electronic system...is considerable and should not 
be underestimated” [34]. The authors believe that the implementation of ETP should 
be treated by the NHS as a change management project, with the consequent stages of 
unfreezing, moving and re-freezing of stakeholder positions and should not be rushed. 
Without adequate stakeholder education and persuasion, the forces that oppose 
change are likely to overwhelm those that want to migrate to ETP. 
 
?? Improved Public Health 
 
Through reform, the UK government’s main aims seem to be improved public health 
through greater and more timely access to services, and cost reductions through 
decreased wastage and greater efficiency, leading to further investment in health care. 
Giversen’s case study in Denmark [47] shows that the use of IT can lead to improved 
public health. Improvements in the prescription processing system could lead to 
improved patient care and overall improved public health [20][48].  However, 
improved public health will only come as a direct result of benefits gained and 
obstacles avoided.  Fewer medication and transcription errors will result in fewer 
medical complications as a result of prescription error. Money saved from the 
consequent reduced litigation and fraud reduction should be used towards the 
provision of better patient care in the NHS. Indeed, Keith Farrar and Ann Slee have 
recently provided significant evidence for this in their literature review of published 
evidence for using electronic prescribing and medicines administration in hospitals 
[44].  The availability of new information and statistics could lead to improved patient 
care.  For example, in research carried out by Kember Associates on behalf of 
Pharmed [45] 12% of patients stated they had failed to collect their medication with 
66% of these stating they had simply forgot. In the more sophisticated ETP 
applications reminder notices could be sent to patients if they have failed to collect 
their prescriptions in a certain period. 
 
Time saved by the pharmacist may lead to improved patient education.  In the UK 
Audit Commission’s national report on medicines management in UK Hospitals, 
Exhibit 18 clearly demonstrates the benefits of ETP to pharmacists “pharmacists are 
able to devote more time to direct patient care” [46].  From their observations in 
practices the authors gained the opinion that the professionals involved would love to 
spend more time educating the patients but presently they are restricted by the paper 
based system.  Clearly if more practitioner’s time can be freed up by ETP then this 
could increase patient care. However, the authors doubt that ETP in itself will do this, 
since the efficiency gains for the pharmacist are likely to be minimal. In fact ETP 
could lead to less patient education and care, as is the case in one UK ETP pilot, 
where the prescriptions are sent to an Internet based pharmacy. Here the drugs are 
dispensed from a central warehouse and then despatched by road to the patient’s 
house, so there is zero contact between the patient and the pharmacist.  
 
The generation of extra statistics and increased communication between healthcare 
providers has the potential to improve public health nationwide. But this will need to 
be managed carefully.  More statistics could be used to coerce prescribers into 
prescribing less costly and less effective drugs, or could be used to show best practice. 
6. Summary 
In this paper we have identified four major categories of issues that will influence the 
implementation of ETP.  When these influences are categorised as positive or 
negative, this results in eight positive influences and nine negative ones as shown in 
Table 1. 
 
The eight positive benefits are realisable with the carefully managed introduction of 
ETP, whilst the nine negative barriers need to be avoided in order to make the 
transition process successful.  We believe that whichever ETP system is chosen 
nationally for the UK, the government should provide clear details about how each of 
the potential benefits are to be realised, and how the potential barriers against 
implementation are to be overcome. 
 
Looking at Table 1 the positive impacts will come from reduced fraud and costs, and 
changes to process and practice, whilst the biggest hurdles the NHS faces is obtaining 
the acceptance of all the stakeholders and overcoming a culture of failure in large 
governmental IT projects.  ETP is a risky path for any government to take. If the 
project is eventually a success and leads to improvements in patient care and the 
efficiency of the UK NHS, the government will be met with widespread public praise, 
whilst delayed transition, escalating costs, or system failure will result in public 
condemnation.  Consequently, the choice of ETP system and implementation strategy 
must be considered with extreme care. 
 
Table 1 Positive and Negative Factors in the Implementation of ETP 
Major Influences Positive (+) Negative (-) 
The Influence of 
Stakeholders 
 
 (-) Government Led 
(-) Senior Management and 
Clinician Resistance to 
Change 
(-) GPs and Pharmacists 
Concerns about its effect on 
Practice and Patient Care 




(-) Privacy and Security 
(-) Technical Problems and 
Process Complexity 
The Influence of 
Cost 
(+)Increased Efficiency and 
Decreased Costs 
(+) Fraud Reduction 
(-) Cost of Transformation 
The Influence of 
Process and Practice 
(+) Medication and 
Transcription Errors 
(+) Repeat Prescribing 
Benefits 
(+) Improved Quality 
(+) Improved Public Health 
(+) Improved Practice 
(-) Legalities 
(-) Multiple Drug Codes 
(-) Education and 
Implementation 
 
Whilst this paper has focused on the introduction of ETP into the UK health service, 
parallels can be drawn with computerising other healthcare systems. A number of the 
identified influences will affect the successful integration of any IT system into the 
health service.  If the government and NHS can instil in their stakeholders a culture of 
change through for example, education, awareness and involvement, then there is the 
potential for the influence of stakeholders to become a positive rather than a negative 
factor. We believe that there is the potential for the government’s investment in 
reform to result in a modernised NHS as long as the change is well planned and the 
stakeholders’ requirements are well catered for. 
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